Robin M. Rathe, MD, MPH

Dr. Timothy Donahue is Chief of the Division of Surgical Oncology and Professor of Surgery at the David Geffen School of Medicine at UCLA. He also has a joint appointment in the Department of Molecular and Medical Pharmacology to facilitate his research program. Dr. Donahue is the Surgical Director of the UCLA Agi Hirshberg Center for Pancreatic Diseases. He is a very busy pancreatic surgeon and performs three to four pancreatic surgeries per week. He is genuinely interested in caring for…

James D. Cherry, MD, MSc is a Distinguished Research Professor at the David Geffen School of Medicine at UCLA and UCLA Mattel Children's Hospital, Division of Infectious Diseases. Dr. Chery received his MD degree from the University of Vermont in 1957 and his MSc degree in Epidemiology from the London School of Hygiene and Tropical Medicine in 1983. He received his pediatric residency training at Boston City Hospital and Kings County Hospital and his infectious diseases fellowship training at the Thorndike Memorial Laboratory, Harvard Medical Service at Boston City Hospital. Following his infectious diseases fellowship training, Dr. Cherry established one of the first formal pediatric infectious disease fellowship programs in the world in 1963 at the University of Wisconsin. In 1973 Dr. Cherry started the first pediatric infectious training program at UCLA. During his 47 years tenure at UCLA, numerous trainees have gone on to be leaders in pediatric infectious diseases in the United States and other countries throughout the world. In 1969-70, Dr. Cherry was a visiting worker at the Medical Research Council, Common Cold Research Unit and Clinical Research Centre, Salisbury, England. From 1989 to 1996, Dr. Cherry and associates carried out an extensive pertussis vaccine efficiency trail in Erlanger, Germany. In 2000-2001, he was a visiting scholar in the Department of Clinical Veterinary Medicine, University of Cambridge, England. In addition, Dr. Cherry was the director of a vaccine reaction study in Denmark at a participant in two USAID nutrition/immunology projects in Kenya. Throughout his career, Dr. Cherry has received numerous national and international awards. Some of these include: The John and Mary B. Markle Scholar in Academic Medicine; Distinguished Physician Award of the Pediatric Infectious Diseases Society; The Stanley A. Plotkin Lectureship in Vaccinology of the Pediatric Infectious Diseases Society; The European Society for Pediatric Infectious Diseases Bill Marshall Award; The American Academy of Pediatrics Section on Infectious Diseases Award for Lifetime Contribution to Infectious Diseases Education; and The UCLA, Edward A. Dickson Emeritus Professorship Award. Dr. Cherry has published 323 research papers, 109 editorials and commentaries and 303 book chapters. He is the senior editor of Feigin and Cherry's Textbook of Pediatric Infectious Disease, which is now in its 8th edition. Dr. Cherry's laboratory experience involved virology, mycoplasmology, serology, and molecular microbiology. His main research over the last 57 years has been related to vaccines and vaccine preventable diseases (measles, rubella, influenza, smallpox, and pertussis). A major interest since 1976 relates to pertussis epidemiology and pertussis vaccines. Over the last 10 years, he and colleagues at the California Department of Public Health and California pediatric infectious diseases physicians have been studying severe pertussis in young infants. Another area of interest has been measles and measles vaccines. He and colleagues first described secondary measles vaccine failure in 1972 in Saint Louis and more recently in California. He presently is involved in measles related studies in the Democratic Republic of the Congo and in Switzerland. Finally, he has been involved in Zika virus studies in Brazil.

Dr. Mark S. Litwin is Professor and Chair of the Department of Urology at UCLA. He trained at Harvard and specializes in testicular, bladder, prostate and kidney cancer. Dr. Litwin’s research focuses on improving quality of care, quality of life, and equitable access to care in urologic oncology. He created and directs IMPACT, a state-funded program that provides free medical care statewide for low-income, uninsured men with prostate cancer. He also leads several national and international…